Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Feb;16(1):192-198.
doi: 10.1007/s12265-022-10296-z. Epub 2022 Aug 8.

Single-Dose St. Thomas Versus Custodiol® Cardioplegia for Right Mini-thoracotomy Mitral Valve Surgery

Affiliations
Observational Study

Single-Dose St. Thomas Versus Custodiol® Cardioplegia for Right Mini-thoracotomy Mitral Valve Surgery

Cristina Barbero et al. J Cardiovasc Transl Res. 2023 Feb.

Abstract

Objective: Custodiol® and St. Thomas cardioplegia are widely employed in mini-thoracotomy mitral valve (MV) operations. One-dose of the former provides 3 h of myocardial protection. Conversely, St. Thomas solution is usually reinfused every 30 min and safety of single delivery is unknown. We aimed to compare single-shot St. Thomas versus Custodiol® cardioplegia.

Methods: Primary endpoint of the prospective observational study was cardiac troponin T level at different post-operative time-points. Propensity-weighted treatment served to adjust for confounding factors.

Results: Thirty-nine patients receiving St. Thomas were compared with 25 patients receiving Custodiol® cardioplegia; cross-clamping always exceeded 45 min. No differences were found in postoperative markers of myocardial injury. Ventricular fibrillation at the resumption of electric activity was more frequent following Custodiol® cardioplegia (P = .01).

Conclusion: Effective myocardial protection exceeding 1 h of ischemic arrest can be achieved with a single-dose St. Thomas cardioplegia in selected patients undergoing right mini-thoracotomy MV surgery.

Keywords: Cardiopulmonary bypass; Crystalloid cardioplegia; Minimally invasive surgery; Mitral valve repair; Myocardial protection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
cTn-T and CK-MB activities. cTn-T: cardiac Troponin T; CK-MB: creatinine kinase-myocardial band; HTK: hystidine-triptophan-ketoglutarate

Similar articles

Cited by

References

    1. Loberman D, Pelletier MP, Yazdchi F, Aranki SF, Preisler Y, Mohr R, et al. Myocardial preservation methods in isolated minimal invasive mitral valve surgery: Society of Thoracic Surgeons (STS) database outcomes. J Card Surg. 2020;35:163–173. doi: 10.1111/jocs.14351. - DOI - PubMed
    1. Bretschneider HJ, Hubner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg. 1975;16:241–260. - PubMed
    1. Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg. 2003;75:661–666. doi: 10.1016/S0003-4975(02)04688-X. - DOI - PubMed
    1. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg. 1980;28:295–302. doi: 10.1055/s-2007-1022099. - DOI - PubMed
    1. Patel N, DeLaney E, Turi G, Stapleton T. Custodiol HTK cardioplegia use in robotic mitral valve. J Extra Corpor Technol. 2013;45:139–142. - PMC - PubMed

Publication types

MeSH terms